Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
doi:10.1016/S0140-6736(23)01053-X PubMed: This trial evaluated retatrutide in 281 participants with type 2 diabetes, showing up to 16.94% weight loss and significant HbA1c reductions with favorable safety profile comparable to other GLP-1 based therapies
Headacheor irritability
For the Schilling Test
Peptiology cannot verify or guarantee compatibility with third-party, unverified, or non-Peptiology peptides
US$ 26.59
US$ 21.45
US$ 20.79
US$ 27.03
US$ 23.07
US$ 28.57
US$ 24.17
US$ 24.79
